MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, EYPT made $966,000 in revenue. -$59,645,000 in net income. Net profit margin of -6174.43%.

Income Overview

Revenue
$966,000
Net Income
-$59,645,000
Net Profit Margin
-6174.43%
EPS
-$0.85
Unit: Dollar
Revenue Breakdown
    • Product
    • Royalty
    • License And Collaboration Agreem...

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Total revenues
966,000 5,333,000 24,453,000 10,378,666.667
Cost of sales
721,000 165,000 805,000 928,000
Research and development
47,754,000 55,498,000 58,574,000 34,461,333.333
Sales and marketing
26,000 35,000 35,000 35,666.667
General and administrative
14,490,000 11,862,000 13,876,000 13,129,333.333
Total operating expenses
62,991,000 67,560,000 73,290,000 47,281,750
Loss from operations
-62,025,000 -62,227,000 -48,837,000 -37,702,000
Interest and other income, net
2,293,000 2,894,000 3,642,000 3,772,000
Interest expense
---3,500
Total other income, net
2,293,000 2,894,000 3,642,000 3,895,666.667
Net loss before income taxes
-59,732,000 -59,333,000 --32,695,000
Provision for income taxes
0 93,000 -22,500
Net loss
-59,732,000 -59,426,000 -45,195,000 -33,836,333.333
Unrealized gain (loss) on available-for-sale securities
87,000 -91,000 -105,000 -71,666.667
Comprehensive income (loss)
-59,645,000 -59,517,000 -45,300,000 -33,908,000
Net loss per share - basic
-0.85 -0.85 -0.65 -0.593
Net loss per share - diluted
-0.85 -0.85 -0.65 -0.593
Weighted average common shares outstanding - basic
70,168 69,926 69,767,000 -18,130,900.667
Weighted average common shares outstanding - diluted
70,168 69,926 69,767,000 -18,130,900.667
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive income (loss)-$59,645,000 Unrealized gain (loss) onavailable-for-sale securities$87,000 Net loss-$59,732,000 Interest and otherincome, net$2,293,000 Net loss beforeincome taxes-$59,732,000 Total other income,net$2,293,000 Royalty$234,000 License AndCollaboration Agreement$150,000 Product$582,000 Loss from operations-$62,025,000 Total revenues$966,000 Total operatingexpenses$62,991,000 General andadministrative$14,490,000 Sales and marketing$26,000 Research and development$47,754,000 Cost of sales$721,000

EyePoint Pharmaceuticals, Inc. (EYPT)

EyePoint Pharmaceuticals, Inc. (EYPT)